Literature DB >> 22605838

Mycobacterium intracellulare infection in non-HIV infected patient in a region with a high burden of tuberculosis.

Fredrick Haraka1, Liliana Kokusanilwa Rutaihwa, Manuel Battegay, Klaus Reither.   

Abstract

Data on non-tuberculous Mycobacteria (NTM) infection in non-HIV patients in Tanzania are scarce. However, NTM infections are emerging in Africa as in many parts of the world. Healthcare providers and physicians working in high tuberculosis incidence regions should also consider NTM as one of the differential diagnosis. A 35-year-old Tanzanian man presented with history of cough, fever, chest pain and night sweats for 4 weeks. The patient had a history of tuberculosis 4 years ago. On physical examination, there were no significant findings. Sputum smears were positive for acid fast bacilli, while Xpert MTB/RIF showed negative results. Culture and subsequent differentiation confirmed Mycobacterium intracellulare infection. With no specific national guidelines at our setting the patient received standard antituberculosis treatment and is kept under close follow-up.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22605838      PMCID: PMC3351644          DOI: 10.1136/bcr.01.2012.5713

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients.

Authors:  M Dailloux; M L Abalain; C Laurain; L Lebrun; C Loos-Ayav; A Lozniewski; J Maugein
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

3.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

4.  Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease.

Authors:  Yun Su Sim; Hye Yun Park; Kyeongman Jeon; Gee Young Suh; O Jung Kwon; Won-Jung Koh
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

5.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

6.  Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Authors:  Catharina C Boehme; Mark P Nicol; Pamela Nabeta; Joy S Michael; Eduardo Gotuzzo; Rasim Tahirli; Ma Tarcela Gler; Robert Blakemore; William Worodria; Christen Gray; Laurence Huang; Tatiana Caceres; Rafail Mehdiyev; Lawrence Raymond; Andrew Whitelaw; Kalaiselvan Sagadevan; Heather Alexander; Heidi Albert; Frank Cobelens; Helen Cox; David Alland; Mark D Perkins
Journal:  Lancet       Date:  2011-04-18       Impact factor: 79.321

Review 7.  Nontuberculous mycobacteria in respiratory tract infections, eastern Asia.

Authors:  Sami Simons; Jakko van Ingen; Po-Ren Hsueh; Nguyen Van Hung; P N Richard Dekhuijzen; Martin J Boeree; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

8.  Invasive disease caused by nontuberculous mycobacteria, Tanzania.

Authors:  John A Crump; Jakko van Ingen; Anne B Morrissey; Martin J Boeree; Daudi R Mavura; Britta Swai; Nathan M Thielman; John A Bartlett; Henning Grossman; Venance P Maro; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

9.  Nontuberculous mycobacteria, zambia.

Authors:  Patricia C A M Buijtels; Marianne A B van-der-Sande; Cas S de-Graaff; Shelagh Parkinson; Henri A Verbrugh; Pieter L C Petit; Dick van-Soolingen
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

  9 in total
  2 in total

1.  Non-tuberculous Mycobacteria isolated from Pulmonary samples in sub-Saharan Africa - A Systematic Review and Meta Analyses.

Authors:  Catherine Okoi; Suzanne T B Anderson; Martin Antonio; Sarah N Mulwa; Florian Gehre; Ifedayo M O Adetifa
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

2.  Species diversity of non-tuberculous mycobacteria isolated from humans, livestock and wildlife in the Serengeti ecosystem, Tanzania.

Authors:  Bugwesa Z Katale; Erasto V Mbugi; Louise Botha; Julius D Keyyu; Sharon Kendall; Hazel M Dockrell; Anita L Michel; Rudovick R Kazwala; Mark M Rweyemamu; Paul van Helden; Mecky I Matee
Journal:  BMC Infect Dis       Date:  2014-11-18       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.